Huntington's disease: pathogenesis, diagnosis and treatment.
- 1 November 1994
- journal article
- review article
- Vol. 19 (5), 359-67
Abstract
This review of the clinical features of Huntington's disease incorporates recent developments in pathophysiology, preclinical diagnosis and treatment. Although the mechanism initiating and guiding the cell destruction in this illness is currently unknown, the excitatory neurotoxin and the energy metabolism models may provide a valuable direction for future research. Similarly, although the precise relation between the neuroanatomical damage in Huntington's disease and the functional disability is not clear, applications of recently developed neural connection models have implicated a number of important brain-behavior associations. Preclinical diagnostic procedures have evolved through successive iterations that have each contributed to increased reliability. New functional brain imaging techniques are sure to add to this promising domain in the future. Preclinical diagnosis has been stimulated by the recent isolation of the Huntington's gene which has also rekindled awareness of the importance of informed genetic counselling and the inherent ethical dilemmas in genetic testing. Treatment approaches to Huntington's disease have been confined to palliative care with secondary symptom management and psychotherapeutic support. Experimental therapeutic strategies for the illness itself have had a rather disappointing record to date. Further developments in NMDA antagonism and neural cell grafting may provide some hope for the future.This publication has 88 references indexed in Scilit:
- Mitochondrial Impairment Reduces the Threshold for in Vivo NMDA-Mediated Neuronal Death in the StriatumExperimental Neurology, 1993
- Evidence of presymptomatic cognitive decline in Huntington's diseaseJournal of Clinical and Experimental Neuropsychology, 1992
- Stereotactic Technique and Pathophysiological Mechanisms of Neurotransplantation in Huntington's ChoreaStereotactic and Functional Neurosurgery, 1992
- Patterns of inheritance of the symptoms of Huntington's disease suggestive of an effect of genomic imprinting.Journal of Medical Genetics, 1991
- A controlled clinical trial of baclofen as protective therapy in early huntington's diseaseAnnals of Neurology, 1989
- Correlates of early disability in Huntington's diseaseAnnals of Neurology, 1986
- Huntingtons DiseaseNew England Journal of Medicine, 1986
- Huntington'S disease: Treatment with muscimol, A GABA‐mimetic drugAnnals of Neurology, 1978
- The EEG in Huntington's chorea: a clinical and neuropathological studyJournal of Neurology, Neurosurgery & Psychiatry, 1972
- Socio-Psychiatric Consequences of Huntington's DiseaseThe British Journal of Psychiatry, 1970